DNA with a twist: New company to search for cancer drugs and antibiotics

User rating: not rated yet

DNA Topoisomerase molecule. Credit: JIC
DNA Topoisomerase molecule. Credit: JIC

A new company has joined the fight against MRSA and cancer. Researchers at the John Innes Centre (Norwich) have launched a new company, Inspiralis Ltd, based around their expertise in DNA topoisomerases – a group of enzymes that help DNA molecules to unravel and wind up properly and not to become tangled during replication.


Full story »
All News summaries from Medicine & Health news
All News summaries for February 13, 2008

Researchers discover baldness gene: 1 in 7 men at risk

7 hours ago | User rating: not rated yet
Researchers at McGill University, King's College London and GlaxoSmithKline Inc. have identified two genetic variants in caucasians that together produce an astounding sevenfold increase the risk of male pattern baldness. ...

Body's anti-HIV drug explained

7 hours ago | User rating: not rated yet
Humans have a built-in weapon against HIV, but until recently no one knew how to unlock its potential.

Pandemic flu models help determine food distribution and school closing strategies

7 hours ago | User rating: not rated yet
The 1918 flu pandemic killed more than 40 million people worldwide and affected persons of all age groups. While it is difficult to predict when the next influenza pandemic will occur or how severe it will be, researchers ...

Study reveals that signs of heart disease are attributed to stress more frequently in women than men

9 hours ago | User rating: not rated yet
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), found that coronary heart disease (CHD) symptoms presented ...

Drug may reduce coronary artery plaque

9 hours ago | User rating: not rated yet
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggests that olmesartan, a drug commonly used to treat ...
Goto Archive PhysOrg Forum Goto Archive Video Goto Archive Editorials Goto Archive Free Magazines Goto Archive Newsletter

News Archive